Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Using reverse docking to identify potential targets for ginsenosides

  • Park, Kichul (Department of Bioinformatics, Korea University) ;
  • Cho, Art E. (Department of Bioinformatics, Korea University)
  • Received : 2016.05.06
  • Accepted : 2016.10.25
  • Published : 2017.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ginsenosides are the main ingredients of ginseng, which, in traditional Eastern medicine, has been claimed to have therapeutic values for many diseases. In order to verify the effects of ginseng that have been empirically observed, we utilized the reverse docking method to screen for target proteins that are linked to specific diseases. Methods: We constructed a target protein database including 1,078 proteins associated with various kinds of diseases, based on the Potential Drug Target Database, with an added list of kinase proteins. We screened 26 kinds of ginsenosides of this target protein database using docking. Results: We found four potential target proteins for ginsenosides, based on docking scores. Implications of these "hit" targets are discussed. From this screening, we also found four targets linked to possible side effects and toxicities, based on docking scores. Conclusion: Our method and results can be helpful for finding new targets and developing new drugs from natural products.

Keywords

References

  1. Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000;71:S1-5. https://doi.org/10.1016/S0367-326X(00)00170-2
  2. Paul N, Kellenberger E, Bret G, Muller P, Rognan D. Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins Struct Funct Bioinform 2004;54:671-80. https://doi.org/10.1002/prot.10625
  3. Kharkar PS, Warrier S, Gaud RS. Reverse docking: a powerful tool for drug repositioning and drug rescue. Fut Med Chem 2014;6:333-42. https://doi.org/10.4155/fmc.13.207
  4. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3:935-49. https://doi.org/10.1038/nrd1549
  5. Chong CR, Sullivan DJ. New uses for old drugs. Nature 2007;448:645-6. https://doi.org/10.1038/448645a
  6. Harvey AL. Natural products in drug discovery. Drug Discov Today 2008;13:894-901. https://doi.org/10.1016/j.drudis.2008.07.004
  7. Shin BK, Kwon SW, Park JH. Chemical diversity of ginseng saponins from Panax ginseng. J Ginseng Res 2015;39:287-98. https://doi.org/10.1016/j.jgr.2014.12.005
  8. Namba T, Matsushige K, Morita T, Tanaka O. Saponins of plants of Panax species collected in central Nepal and their chemotaxonomical significance. I. Chem Pharm Bull 1986;34:730-8. https://doi.org/10.1248/cpb.34.730
  9. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Studies on the saponin of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rc, and -Rd. Chem Pharm Bull 1974;22:421-8. https://doi.org/10.1248/cpb.22.421
  10. Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med 2010;5:20. https://doi.org/10.1186/1749-8546-5-20
  11. Chen X, Ung CY, Chen Y. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? Nat Prod Rep 2003;20:432-44. https://doi.org/10.1039/b303745b
  12. Cai J, Han C, Hu T, Zhang J, Wu D, Wang F, Liu Y, Ding J, Chen K, Yue J, et al. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci 2006;15:2071-81. https://doi.org/10.1110/ps.062238406
  13. Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008;9:104. https://doi.org/10.1186/1471-2105-9-104
  14. Zahler S, Tietze S, Totzke F, Kubbutat M, Meijer L, Vollmar AM, Apostolakis J. Inverse in silico screening for identification of kinase inhibitor targets. Chem Biol 2007;14:1207-14. https://doi.org/10.1016/j.chembiol.2007.10.010
  15. Chen YZ, Ung CY. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligandeprotein inverse docking approach. J Mol Graph Mod 2001;20:199-218. https://doi.org/10.1016/S1093-3263(01)00109-7
  16. Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, et al. PubChem Substance and Compound databases. Nucl Acids Res 2016;44:D1202-13. https://doi.org/10.1093/nar/gkv951
  17. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739-49. https://doi.org/10.1021/jm0306430
  18. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750-9. https://doi.org/10.1021/jm030644s
  19. Choi YJ, Lee HJ, Kang DW, Han IH, Choi BK, Cho WH. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species. Oncol Rep 2013;30:1362-70. https://doi.org/10.3892/or.2013.2555
  20. Sathishkumar N, Karpagam V, Sathiyamoorthy S, Woo MJ, Kim YJ, Yang DC. Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng. Comput Biol Med 2013;43:786-97. https://doi.org/10.1016/j.compbiomed.2013.02.020
  21. Zhou Q, Jiang L, Xu C, Luo D, Zeng C, Liu P, Yue M, Liu Y, Hu X, Hu H. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res 2014;133:57-65. https://doi.org/10.1016/j.thromres.2013.10.032
  22. Joo CN, Kim SJ. Effect of ginseng components (ginsenosides and fat soluble fraction) on rat liver glucokinase activity. Korean Soc Ginseng 1994;18:1-9.
  23. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268:14553-6.
  24. Singh P, Bast F. In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor. Med Chem Res 2014;23:5074-85. https://doi.org/10.1007/s00044-014-1090-1
  25. Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol 2014;35:5593-8. https://doi.org/10.1007/s13277-014-1739-x
  26. Banner DW, Hadvary P. Crystallographic analysis at $3.0-{\AA}$ resolution of the binding to human thrombin of four active site-directed inhibitors. J Biol Chem 1991;266:20085-93.
  27. Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, Scagliotti GV. Aurora kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. J Transl Med 2011;9:100. https://doi.org/10.1186/1479-5876-9-100
  28. Umene K, Banno K, Kisu I, Yanokura M, Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, et al. Aurora kinase inhibitors: potential molecular targeted drugs for gynecologic malignant tumors (review). Biomed Rep 2013;1:335-40. https://doi.org/10.3892/br.2013.91
  29. Dodds HM, Rivory LP. The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11). Mol Pharm 1999;56:1346-53. https://doi.org/10.1124/mol.56.6.1346
  30. Zhang B, MacNaul K, Szalkowski D, Li Z, Berger J, Moller DE. Inhibition of adipocyte differentiation by HIV protease inhibitors. J Clin Endocrinol Metab 1999;84:4274-7. https://doi.org/10.1210/jcem.84.11.6234
  31. Bryla J, Lietz T, Jarzyna R, Michalik M, Pietkiewicz J. Differential in vivo and in vitro effect of gentamicin on glutamate synthesis and glutamate deamination in rabbit kidney-cortex tubules and mitochondria. Pharmacol Res 1992;26:367-75. https://doi.org/10.1016/1043-6618(92)90235-4
  32. Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharm 2012;3:25.
  33. Kim JH. Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res 2012;36:16-26. https://doi.org/10.5142/jgr.2012.36.1.16

Cited by

  1. In silico analysis and in vivo tests of the tuna dark muscle hydrolysate anti-oxidation effect vol.8, pp.25, 2017, https://doi.org/10.1039/c8ra00889b
  2. In silico analysis and in vivo tests of the tuna dark muscle hydrolysate anti-oxidation effect vol.8, pp.25, 2017, https://doi.org/10.1039/c8ra00889b
  3. Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds vol.6, pp.None, 2018, https://doi.org/10.3389/fchem.2018.00138
  4. The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner vol.7, pp.11, 2017, https://doi.org/10.1002/cam4.1800
  5. In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate vol.24, pp.7, 2017, https://doi.org/10.3390/molecules24071445
  6. Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis vol.71, pp.5, 2017, https://doi.org/10.1002/iub.1984
  7. Molecular Docking: Shifting Paradigms in Drug Discovery vol.20, pp.18, 2019, https://doi.org/10.3390/ijms20184331
  8. 6′-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis vol.51, pp.10, 2017, https://doi.org/10.1038/s12276-019-0311-6
  9. A Machine Learning-Based Biological Drug-Target Interaction Prediction Method for a Tripartite Heterogeneous Network vol.6, pp.4, 2017, https://doi.org/10.1021/acsomega.0c05377
  10. Application of Reverse Docking in the Research of Small Molecule Drugs and Traditional Chinese Medicine vol.45, pp.1, 2017, https://doi.org/10.1248/bpb.b21-00324